FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/084832 [Registered on: 15/04/2025] Trial Registered Prospectively
Last Modified On: 15/04/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Strength Training in Parkinsons Disease 
Scientific Title of Study   Strength Training as an Add-on to Standard Pharmacotherapy in Patients with Parkinsons Disease: A Randomized Controlled Biomarker Trial (SToP-PD)  
Trial Acronym  SToP-PD 
Secondary IDs if Any  
Secondary ID  Identifier 
I-NK/NEUROLOGY/SToP-PD/2024 Ver.01 Dated October 28, 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Supriyo Choudhury 
Designation  Assistant Director of Research 
Affiliation  Institute of Neurosciences Kolkata 
Address  Institute of Neurosciences Kolkata, 9th floor, Department of Neurology, Research room, 185/1, AJC Bose Road, Kolkata 700017

Kolkata
WEST BENGAL
700017
India 
Phone  9433106238  
Fax    
Email  choudhurydrsupriyo@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Supriyo Choudhury 
Designation  Assistant Director of Research 
Affiliation  Institute of Neurosciences Kolkata 
Address  Institute of Neurosciences Kolkata, 9th floor, Department of Neurology, Research room, 185/1, AJC Bose Road, Kolkata 700017

Kolkata
WEST BENGAL
700017
India 
Phone  9433106238  
Fax    
Email  choudhurydrsupriyo@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Supriyo Choudhury 
Designation  Assistant Director of Research 
Affiliation  Institute of Neurosciences Kolkata 
Address  Institute of Neurosciences Kolkata, 9th floor, Department of Neurology, Research room, 185/1, AJC Bose Road, Kolkata 700017

Kolkata
WEST BENGAL
700017
India 
Phone  9433106238  
Fax    
Email  choudhurydrsupriyo@gmail.com  
 
Source of Monetary or Material Support  
Institute of Neurosciences Kolkata, 185/1, AJC Bose Road, Kolkata 700017 
 
Primary Sponsor  
Name  Indian Council of Medical Research(ICMR) 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Supriyo Choudhury  Institute of Neurosciences Kolkata  Institute of Neurosciences Kolkata, 9th floor, Department of Neurology, Research room, 185/1, AJC Bose Road, Kolkata 700017
Kolkata
WEST BENGAL 
9433106238

choudhurydrsupriyo@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, Institute of Neurosciences Kolkata  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G20||Parkinsons disease,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Standard of care   Standard Pharmacotherapy for Parkinsons Disease 
Intervention  Strength training   The intervention will be a total of 12 weeks long, where participants will be trained by an experienced physiotherapist on the date of screening and on Day2. The training sessions will be AV recorded in patients’ mobile camera, for future reference. The patients will perform assisted (by caregiver) home-based training three days a week (every alternate day with Sunday off). The patients will be requested to come once every fortnight for an hour-long session for monitoring of muscle strength and progressive increase in resistance (when needed).The patients on ST group will be prescribed three sets of 8 repetitions at 60-70% of their one repetition maximum (1-RM), as determined during their pre-test(6). Knee extension, hip flexion, foot dorsiflexion, biceps curl, power grip, and lateral raise exercises etc. will be advised for the training using inexpensive free weights like adjustable leg and wrist weighted bands. A warmup and cool down period will be taught to initiate and conclude the training sessions respectively. The duration of the session should remain between 30 mins to one hour. 
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  Individuals diagnosed with Idiopathic Parkinsons disease according to MDS clinical diagnostic criteria. Patients of either sex between the age of 40 to 75 years and Hoehn and Yahr stages 1 to 3 who can stand unassisted for two minutes and having a clinically apparent gait problem will be included in the study. Patients will require access to smartphone for AV recording and viewing the training program. Patient must have a study partner who will assist him/ her in the domiciliary training sessions. 
 
ExclusionCriteria 
Details  PD patients with dyskinesia will not be enrolled. Patients with significant musculoskeletal problems or chronic pain, which might be aggravated by training or interfere with the outcome as perceived by the PI/ Co-I, will be excluded. Patients with a neurological disease other than PD or other physical impairments that would prevent participation in the muscular strength testing will be excluded on screening. PD patients with uncontrolled systemic diseases (e.g. hypertension, heart diseases, etc.) or significant cognitive impairment or refractory psychiatric symptoms will also be excluded, as will those who are already participating in a structured exercise program (including yoga, regular supervised/unsupervised stretching, or aerobic training). However, those who walk for their fitness regularly, may be included in the study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of changes in muscle strength, motor function and cognition between standard treatment versus add-on strength training (ST) for evaluation of efficacy of ST.  Day 0, week 4, week 8, week 12 (for all) and week 24 (for active intervention group)  
 
Secondary Outcome  
Outcome  TimePoints 
Comparison of changes in electrophysiological biomarkers between standard treatment versus add-on strength training (ST) to understand the mechanism of strength training.  Day 0, week 4, week 8, week 12 (for all) and week 24 (for active intervention group)  
Comparison of reported adverse event frequency and other safety parameters between standard treatment versus add-on strength training (ST) for evaluation of safety of ST.  Day 0, week 4, week 8, week 12 (for all) and week 24 (for active intervention group)  
Comparison of changes in molecular biomarkers between standard treatment versus add-on strength training (ST) to understand the mechanism of strength training.  Day 0, week 12 (for all) and week 24 (for active intervention group)  
 
Target Sample Size   Total Sample Size="122"
Sample Size from India="122" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Rationale/ gaps in existing knowledge: Parkinson’s Disease (PD) currently affects around 1% of the population over sixty years of age, however, prevalence is expected to increase. In preliminary studies, lower limb strength training was effective at alleviating motor symptoms of PD, when used in conjunction with standard pharmacotherapy. The proposed study will provide definitive data on the efficacy and safety of strength training in PD patients, with particular relevance to India.
Novelty: In addition to assessing efficacy and safety in the first ever randomized controlled trial (RCT) of strength training in India, the current study will throw light on novel mechanistic aspects, focussing on neural adaptations underpinning strength training. For the first time, we will explore the role of the Reticulospinal Tract (RST) in improving strength and motor symptoms in PD.
Objectives: Assess the safety and efficacy of strength training as an add-on to standard pharmacotherapy for improvement of motor function, gait, selective non-motor functions in PD patients. Additionally, we will elucidate the mechanism of improvement through changes in molecular and electrophysiological biomarkers following strength training.
Methods: A randomized controlled trial will be conducted on PD patients with gait impairment. The patients will be assigned to either strength training or no physical therapy groups in addition to stable dose of standard medications for 12 weeks. Clinical, electrophysiological outcomes and molecular biomarkers will be assessed at baseline and at 12 weeks. A post-treatment follow-up visit will be performed on active intervention group for similar assessments at week 24 to find out any carryover effect of strength training.
 
Close